Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Herzog, A. G.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Herzog, A. G.
Related Collections
* Epilepsy
Psychosomatics 40:102-108, April 1999
© 1999 The Academy of Psychosomatic Medine


Special Article

Psychoneuroendocrine Aspects of Temporolimbic Epilepsy

Part II: Epilepsy and Reproductive Steroids

Andrew G. Herzog, M.D., M.Sc.

Received April 28, 1998; revised September 10, 1998; accepted October 6, 1998. From Harvard Neuroendocrine Unit, Beth Israel Deaconess Medical Center, Department of Neurology, Harvard Medical School, Boston, MA. Address reprint requests to Dr. Herzog, Neuroendocrine Unit, Beth Israel Deaconess Medical Center, 330 Brookline Ave., Boston, MA 02215.

Reproductive dysfunction is unusually common among men and women with epilepsy. Reproductive endocrine disorders are also common and may be causal. The association between particular reproductive endocrine disorders and the laterality and focality of epileptiform discharges suggests an etiologic role for epilepsy. Gonadal steroids are neuroactive and influence seizure occurrence: estrogen is epileptogenic whereas progesterone has antiseizure effects. Fluctuations in the absolute and relative serum levels of these hormones may play a critical role in establishing three distinct patterns of catamenial epilepsy: 1) perimenstrual and 2) preovulatory in women with ovulatory cycles, and 3) entire luteal phase of the cycle in women with anovulatory cycles. Treatment with progesterone reduces seizure frequency by more than half. In men, testosterone effects may depend on the relative concentrations of two major testosterone metabolites that exert opposing influences on neuronal excitability: estrogen potentiates whereas dihydrotestosterone inhibits NMDA-mediated conductance. Combined therapy using an aromatase inhibitor along with testosterone improves sexual function and may reduce seizures in men with epilepsy.

Key Words: Neuropsychiatric Disorders • Epilepsy • Steroids




This article has been cited by other articles:


Home page
J Intellect DisabilHome page
T. Thompson, M. Caruso, and K. Ellerbeck
Sex Matters in Autism and Other Developmental Disabilities
J Intellect Disabil., December 1, 2003; 7(4): 345 - 362.
[Abstract] [PDF]


Home page
Hum ReprodHome page
W. H. James
The data sources which may help strengthen the epidemiological evidence for the hormonal hypothesis of sex determination in man
Hum. Reprod., June 1, 2001; 16(6): 1081 - 1085.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. S. Reddy and M. A. Rogawski
Chronic Treatment with the Neuroactive Steroid Ganaxolone in the Rat Induces Anticonvulsant Tolerance to Diazepam but Not to Itself
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1241 - 1248.
[Abstract] [Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1999 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org